Our partner is focused on developing gene therapies for heart disease, particularly those related to genetic mutations and cardiac dysfunction. Their innovative approach aims to repair or replace defective genes to restore heart function, offering transformative solutions for patients with serious cardiovascular conditions.

This critical hire provided expert guidance on regulatory strategies and ensured compliance with global regulations. They led the preparation and submission of regulatory documents, interacted with regulatory agencies, and developed strategies to support product development and market approvals.